Does AGALSIDASE ALFA Cause Poor venous access? 17 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Poor venous access have been filed in association with AGALSIDASE ALFA. This represents 15.7% of all adverse event reports for AGALSIDASE ALFA.
17
Reports of Poor venous access with AGALSIDASE ALFA
15.7%
of all AGALSIDASE ALFA reports
1
Deaths
14
Hospitalizations
How Dangerous Is Poor venous access From AGALSIDASE ALFA?
Of the 17 reports, 1 (5.9%) resulted in death, 14 (82.4%) required hospitalization.
Is Poor venous access Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AGALSIDASE ALFA. However, 17 reports have been filed with the FAERS database.
What Other Side Effects Does AGALSIDASE ALFA Cause?
Fatigue (40)
Inappropriate schedule of product administration (40)
Malaise (28)
Headache (27)
Cough (26)
Nausea (26)
Blood pressure decreased (25)
Covid-19 (25)
Dizziness (25)
Pain (25)
What Other Drugs Cause Poor venous access?
VEDOLIZUMAB (1,043)
INFLIXIMAB (917)
INFLIXIMAB-DYYB (782)
ECULIZUMAB (555)
HUMAN IMMUNOGLOBULIN G (504)
NATALIZUMAB (422)
RITUXIMAB (299)
TOCILIZUMAB (287)
METHOTREXATE (257)
ABATACEPT (249)
Which AGALSIDASE ALFA Alternatives Have Lower Poor venous access Risk?
AGALSIDASE ALFA vs AGALSIDASE BETA
AGALSIDASE ALFA vs AGOMELATINE
AGALSIDASE ALFA vs ALAWAY
AGALSIDASE ALFA vs ALBENDAZOLE
AGALSIDASE ALFA vs ALBIGLUTIDE